GlassScriptPhysician profile
Angela C Mount
NPI 1821308032
$289.22
in general payments reported to CMS, 2019-2025
10 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.98 · 2023: $35.70 · 2024: $90.34 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $49.50 | 2023-2024 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $42.36 | 2024-2025 | Veozah |
| Lilly USA, LLC | $40.53 | 2024-2025 | Jardiance, Zepbound, Mounjaro |
| Tactile Systems Technology INC | $34.21 | 2024 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $31.90 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $29.88 | 2025 | Rexulti |
| Viatris Specialty LLC | $20.40 | 2025 | Yupelri |
| Sumitomo Pharma America, INC. | $15.46 | 2025 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $13.31 | 2021 | |
| Hologic Sales and Service, LLC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mount listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.